Skip to main content
NanoRepro AG logo

NanoRepro AG — Investor Relations & Filings

Ticker · NN6 ISIN · DE0006577109 LEI · 3912008FCA63AGIMEV74 F Manufacturing
Open in API
Filings indexed 413 across all filing types
Latest filing 2018-07-11 Earnings Release
Country DE Germany
Listing F NN6

About NanoRepro AG

https://www.nanorepro.com/en/

NanoRepro AG is a company specializing in the development, manufacturing, and distribution of CE-marked rapid diagnostic tests (self-tests) and food supplements. The products are designed for both home and professional use. The company's portfolio covers various health areas, including family planning, preventive healthcare, disease detection, food intolerances, allergies, and infectious diseases. The primary goal is to provide accuracy in self-diagnostics for rapid disease detection and health monitoring.

Recent filings

Filing Released Lang Actions
NanoRepro AG: Erstes Halbjahr 2018 bestatigt Wachstumskurs
Earnings Release Classification · 100% confidence The document is titled 'NanoRepro AG: Erstes Halbjahr 2018 bestätigt Wachstumskurs' (First Half of 2018 confirms growth trajectory) and explicitly mentions preliminary figures for the '1. Halbjahr 2018' (First Half 2018), including revenue and EBITDA expectations. This content structure—a brief announcement highlighting key financial metrics for a period shorter than a full year—is characteristic of an Interim/Quarterly Report announcement, even though it states final audited figures will follow later. The presence of 'Halbjahresergebnis' (Half-year result) in the keywords strongly points to the Interim Report category (IR). It is not a full 10-K, nor is it just a generic announcement of a report (RPA), as it contains the actual preliminary results summary. H1 2018
2018-07-11 German
Datum:09.07.2018
Annual Report Classification · 100% confidence The document is titled 'Jahresabschluss zum Geschäftsjahr vom 01.01.2017 bis zum 31.12.2017' (Annual Financial Statement for the fiscal year 2017) and includes a 'Lagebericht' (Management Report). This is a comprehensive annual financial report for NanoRepro AG. While it contains management discussion, the primary nature of the document is the full annual financial reporting package, which corresponds to the 10-K category in the provided schema. FY 2017
2018-07-09 German
DGAP-DD: NanoRepro AG english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a 'Notification and public disclosure of transactions by persons discharging managerial responsibilities'. It details a transaction (Acquisition) by an individual named Michael Fuchs, identified as a 'Member of the managing body' of NanoRepro AG, including the date, price, and volume of shares traded. This directly corresponds to the definition of Director's Dealing.
2018-06-27 English
DGAP-DD: NanoRepro AG english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section header 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details the name of the associated person (Regina Kern, closely associated with Dr. Michael Kern, a Member of the administrative or supervisory body), the nature of the transaction ('Acquisition'), the price, volume, and date of the transaction involving NanoRepro AG shares. This content directly matches the definition for Director's Dealing.
2018-06-27 English
NanoRepro AG: Eintragung der Kapitalerhohung erfolgt
Share Issue/Capital Change Classification · 99% confidence The document is a news release from NanoRepro AG, dated June 27, 2018, announcing that the registration of a capital increase ('Eintragung der Kapitalerhöhung erfolgt') in the commercial register has been completed. It details the issuance of 1,640,458 new shares, the resulting increase in share capital, and the intended use of the proceeds (marketing, e-commerce, product innovation). This content directly relates to changes in the company's capital structure and fundraising activities. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). Although it mentions the registration, the core subject is the capital change itself, not just the announcement of a report.
2018-06-27 German
NanoRepro AG: Enormes Interesse an Kapitalerhohung
Capital/Financing Update Classification · 99% confidence The document is a news release dated June 15, 2018, titled "NanoRepro AG: Enormes Interesse an Kapitalerhöhung" (Enormous interest in capital increase). It details the successful placement of new shares, the gross proceeds (€2,083,381.66), the increase in share capital, and the intended use of the proceeds (financing marketing and product innovation). This content directly relates to fundraising, financing activities, and capital structure changes. This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it describes a specific corporate financing event.
2018-06-15 German

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.